Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Satori Pharmaceuticals makes appointments

This article was originally published in Scrip

Executive Summary

Satori Pharmaceuticals (US), a company focused on the development of disease-modifying therapies for Alzheimer's disease, has appointed Steven Holtzman as chair of its board of directors and Jeff Jonker as chief business officer. Mr Holtzman, executive chair and co-founder of Infinity Pharmaceuticals, recently joined Satori's board, while Mr Jonker was most recently vice-president of business development and strategic planning at Gloucester Pharmaceuticals.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC008579

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel